The Maine Health Data Organization (MHDO) is mandated to collect pricing component data from prescription drug manufacturers, wholesale drug distributors, and pharmacy benefit managers. This data includes information on costs and payments related to making prescription drugs available to consumers.

4 views • 25 slides

NIMH's Clinical Monitoring and Clinical Research Education, Support, and Training Program (CREST) aims to ensure the proper conduct, recording, and reporting of clinical trials. This program includes clinical monitoring plans, guidelines for site monitoring activities, and independent clinical monit

1 views • 29 slides

Polymeric controlled drug delivery systems play a crucial role in regulating drug release through diffusion, solvent penetration, and chemical mechanisms. These systems include diffusion-controlled, solvent-controlled, and chemically-controlled devices, each operating based on specific principles. S

0 views • 33 slides

Nasopulmonary drug delivery system, utilizing the nasal route for drug administration, offers advantages such as hepatic first-pass metabolism avoidance and rapid drug absorption. This system is beneficial for pharmacologically active compounds with poor stability in gastrointestinal fluids. While i

0 views • 35 slides

Enrollment in Medicare stand-alone prescription drug plans slightly declined between 2020 and 2021. The rates of enrollment vary between rural and urban states, with higher enrollment in rural states with low Medicare Advantage rates. Across counties, enrollment in prescription drug plans ranges fro

1 views • 13 slides

In drug development, in-vitro dissolution testing plays a crucial role in evaluating drug release from tablets when in-vivo bioavailability studies are limited. By ensuring drug release is close to 100% and uniform batch to batch, these tests help assess drug availability and effectiveness. Regulato

10 views • 10 slides

Explore the quantitative aspects of drug action, including drug receptor binding, concentration binding curves, dose-response curves, and types of antagonism. Learn to relate drug concentration to receptor binding capacity and response produced. Discover how concentration binding curves and dose-res

0 views • 29 slides

Drug abuse is a serious issue involving various substances like prescription drugs, alcohol, and illegal drugs. This includes terms and definitions, effects on the body and mind, stages of addiction, and withdrawal symptoms. Factors influencing drug action and reasons for drug use are also explored.

4 views • 45 slides

This presentation covers key aspects of monitoring tools for program oversight, including types of monitoring documents, notice of monitoring, and elements to consider. It discusses the importance of informing subawardees about monitoring visits and outlines the components of monitoring forms used i

0 views • 64 slides

Public opinion polls from 2015 to 2020, conducted by KFF Health Tracking Polls, reveal insights on Americans' views on prescription drugs. Key findings include the prevalence of prescription drug use, concerns about affordability, and challenges faced by individuals in affording their medication. Th

2 views • 20 slides

Learn how to calculate the cost of veterinary prescriptions based on total dosage, drug strength, and unit cost. Two scenarios are provided with detailed calculations for determining the total cost of the prescription. Understand how to convert units, calculate total dosage required, determine the n

0 views • 11 slides

Idaho's 24/7 Sobriety & Drug Monitoring Program, led by Program Coordinator Tami J. Faulhaber, aims to reduce recidivism, improve public safety, and act as an alternative to incarceration. Participants undergo regular testing and supervision, enabling them to live soberly in their communities while

0 views • 16 slides

Detailed information on the standard Medicare Part D prescription drug benefit for 2013, including coverage details for catastrophic, brand-name, and generic drugs. Additionally, data on the distribution of Part D plans by benchmark status, weighted average premiums, and premium trends for high-enro

0 views • 22 slides

The Nordic Prescription Registers in Iceland provide detailed data on prescription drug dispensing, covering variables such as drug user information, dispensing details, prescriber data, pharmacy information, and more. The database includes information on all reimbursed and non-reimbursed prescripti

0 views • 11 slides

Prescription drug abuse is a growing concern, with millions of emergency department visits related to drug misuse or abuse annually. Non-compliance and lack of standardization in testing processes add complexity to monitoring and detecting drug abuse. Pain management panels include various opioids,

0 views • 23 slides

Proposal recommendations for the Prescription Drug Task Force in Michigan include enhancing transparency in cost information, holding stakeholders accountable, improving accessibility to drugs from Canada, ensuring affordability through rate setting and tax credits, and implementing measures to addr

0 views • 6 slides

Explore the pharmaceutical perspective on prescription opioids, the impact of pain as a vital sign, sources of misused prescription opioids, non-medical use statistics, heroin trends, and CDC guidelines to limit opioid prescribing. Gain insights on the complexities surrounding opioid misuse and the

0 views • 11 slides

The Virginia Prescription Monitoring Program (PMP) aims to track and analyze prescription drug usage to combat substance abuse. Through a comprehensive database, the program helps healthcare providers, law enforcement, and patients access vital information to prevent misuse and overdose deaths. The

0 views • 15 slides

The integration of Prescription Drug Monitoring Programs (PDMP) in pharmacy practice plays a crucial role in improving clinical decision-making and supporting pharmacists' professional judgment. By discussing the pharmacist's role in dispensing controlled substance prescriptions, assessing the impac

0 views • 40 slides

U.S. prescription drug spending data from 2005 to 2025 shows trends in various payer contributions, with predictions for future years. Medicare Part D's drug spending is broken down, revealing top drugs and rebate percentages. The total Medicare spending in 2015 and average annual growth in Medicare

0 views • 10 slides

Research Department in Finland, led by Leena K. Saastamoinen from The Social Insurance Institution (Kela), focuses on prescription registers and essential demographics, including the size of the population. The department collaborates with relevant institutions and is located in Helsinki. They manag

0 views • 15 slides

Efforts in Lane County to prevent prescription drug overdose include forming alliances, organizing educational sessions for prescribers, promoting Naloxone access, and engaging with the community and law enforcement. Initiatives also involve monitoring and addressing risky prescribing practices and

0 views • 13 slides

The material provides comprehensive information on Medicare prescription drug coverage, including the basics, benefits, costs, eligibility, enrollment, extra help, plan comparisons, coverage determinations, and appeals. It covers the four parts of Medicare and explains the requirements and processes

0 views • 72 slides

This report delves into the sources and parameters of prescription drug coverage in Medicare enrollees with chronic kidney disease (CKD) for the years 2010 to 2015. It explores the trends in Medicare Part D enrollment, out-of-pocket costs, and catastrophic coverage benefits. The data presented sheds

0 views • 20 slides

SPF-Rx is a strategic prevention framework initiated by SAMHSA to address prescription drug abuse, focusing on raising awareness about medication dangers, overprescribing risks, and community prevention activities. The program targets youth aged 12-17 and adults 18+, aiming to combat prescription dr

0 views • 15 slides

This information provides insights into a Prescription Drug Overdose grant program in New Mexico, focusing on training and distributing Naloxone to combat opioid overdose. The program involves a hub and spoke system, where entities like county organizations and local agencies play crucial roles in t

0 views • 22 slides

The Florida Prescription Drug Monitoring Program (PDMP) monthly report for September 2021 provides detailed information on controlled substance dispensations, including the number of prescriptions by drug type and year; opioid, stimulant, and benzodiazepine prescriptions by month; indicators by mont

0 views • 7 slides

The figures depict the alarming rise in drug-involved overdose deaths in the United States over the period 1999-2020. Figure 1 shows the number of deaths by gender, Figure 2 highlights specific drug categories involved, Figure 3 focuses on opioid-related deaths categorized by gender, and Figure 4 de

0 views • 10 slides

Prescription drug spending experienced significant growth in 2014, driven by costly specialty drugs. Medicare emerged as a major payer for prescription medications, with notable increases since 2004. While most individuals can afford their prescription drugs, a significant portion still struggles wi

0 views • 7 slides

The National Association of Drug Diversion Investigators (NADDI) focuses on combating prescription drug diversion through advocacy, training, and collaboration with law enforcement. They address the misuse of opioids like OxyContin and Oxycodone, showing successes in reducing diversion and deaths in

0 views • 14 slides

The World Drug Report 2020 highlights the strong correlation between socioeconomic factors and drug use disorders. Studies reveal that communities facing poverty, violence, and social inequality are at a higher risk of drug overdoses and addiction. Factors like income inequality, lack of social capi

0 views • 17 slides

Targeted clinical investigation plays a crucial role in pharmacovigilance by further evaluating significant risks identified in pre-approval clinical trials. This involves conducting pharmacokinetic and pharmacodynamic studies, genetic testing, interaction studies, and large simplified trials to ass

0 views • 12 slides

Key findings from KFF Health Tracking Polls conducted between 2015-2019 reveal that a significant percentage of Americans face challenges affording prescription drugs despite the widespread use of medication. The survey highlights the impact of costs on medication adherence, showing that many indivi

0 views • 18 slides

This comprehensive training package focuses on active tuberculosis drug safety monitoring and management (aDSM) in 2023. It covers indicators, learning objectives, and essential information for implementing effective drug safety measures in tuberculosis treatment. The presentation emphasizes definin

0 views • 11 slides

This content explores various advanced ophthalmic drug delivery systems including erodible ophthalmic inserts, soluble ocular drug inserts, new ophthalmic drug delivery systems, and bioadhesive ophthalmic drug inserts. These innovative systems aim to provide accurate dosing, prolonged drug release,

0 views • 8 slides

Understanding the dangers of teen prescription drug abuse is crucial for young influencers. This workshop equips teens with knowledge on dispelling myths, communicating effectively, and taking an active role in prevention. By recognizing the risks, such as accidental overdose, addiction, and even de

0 views • 36 slides

Center for Court Innovation has introduced a new National Drug Court Online Learning System aimed at assisting drug court professionals. This system offers free access to web-based training, expert video lessons, virtual site visits to drug treatment courts, practitioner interviews, and a resource l

0 views • 8 slides

Chief Judge John A. Woodcock, Jr. of the United States District Court in Maine discusses the alarming rates of prescription drug abuse in the state. The consequences of this abuse are highlighted, including the staggering number of pharmaceutical overdose deaths, high school seniors using prescripti

0 views • 34 slides

Explore the distinctions between drugs and medicines, understanding side effects, and the importance of prescriptions for certain drugs. Learn about common side effects, prescription medicines, prescription drug abuse, and the roles of different types of medications in our body. Gain insights into r

0 views • 19 slides

The Drug-Free Workplace Act of 1988 mandates federal grant recipients to implement zero-tolerance drug policies to maintain a drug-free environment. Employers must establish clear policies, conduct awareness programs, offer counseling and rehabilitation services, and impose penalties for violations.

0 views • 19 slides